Xiaoyuan Wang Selected Research

Xiaoyuan Wang Research Topics

Disease

28	Neoplasms (Cancer) 02/2022 - 01/2013
9	Infections 07/2022 - 09/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 03/2014
4	Myocardial Infarction 10/2019 - 01/2017
3	Inflammation (Inflammations) 10/2022 - 01/2021
3	Hypertension (High Blood Pressure) 03/2022 - 10/2018
3	Disease Progression 01/2022 - 05/2016
3	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2017
3	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2015
3	Hereditary Nephritis (Alport Syndrome) 11/2021 - 01/2020
3	Carcinoma (Carcinomatosis) 11/2021 - 07/2014
3	Sepsis (Septicemia) 05/2021 - 01/2010
3	Septic Shock (Toxic Shock Syndrome) 05/2021 - 05/2014
3	Fibrosis (Cirrhosis) 02/2021 - 01/2017
3	Infarction (Infarctions) 01/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 11/2018 - 05/2016
2	Cognitive Dysfunction 04/2022 - 02/2022
2	Thymoma (Thymic Carcinoma) 01/2022 - 02/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2021 - 05/2014
2	Hypoxia (Hypoxemia) 03/2021 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2020 - 10/2018
1	Proteinuria 12/2022
1	Hemolytic-Uremic Syndrome 12/2022
1	Weight Gain 10/2022
1	Body Weight (Weight, Body) 10/2022
1	Atrial Fibrillation 04/2022
1	Alzheimer Disease (Alzheimer's Disease) 04/2022
1	Nervous System Diseases (Neurological Disorders) 02/2022
1	Myasthenia Gravis 01/2022
1	Hyperthermia 01/2022
1	Whooping Cough (Pertussis) 01/2022
1	Starvation 12/2021
1	Esophageal Squamous Cell Carcinoma 11/2021
1	Esophageal Neoplasms (Esophageal Cancer) 11/2021
1	Neuromyelitis Optica (Devic's Disease) 10/2021

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2022 - 05/2016
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2014
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2011
7	MicroRNAs (MicroRNA)IBA 05/2019 - 12/2015
5	Messenger RNA (mRNA)IBA 11/2021 - 01/2017
4	Long Noncoding RNAIBA 10/2021 - 10/2018
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2018 - 07/2014
3	AntioxidantsIBA 10/2022 - 12/2015
3	CytokinesIBA 04/2022 - 11/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 01/2022
3	Lipid AIBA 10/2016 - 12/2004
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2022 - 10/2021
2	LipidsIBA 10/2022 - 03/2021
2	Circular RNAIBA 01/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2018
2	RNA (Ribonucleic Acid)IBA 11/2021 - 10/2021
2	Laminin (Merosin)IBA 05/2020 - 01/2019
2	CollagenIBA 10/2019 - 01/2017
2	Tissue Inhibitor of Metalloproteinase-1IBA 10/2019 - 01/2012
2	Competitive Endogenous RNAIBA 10/2019 - 10/2018
2	Ethylene Glycol (Monoethylene Glycol)IBA 11/2018 - 01/2018
2	poly-N-isopropylacrylamideIBA 11/2018 - 01/2018
2	poly(2-(dimethylamino)ethyl methacrylate)IBA 02/2018 - 11/2017
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 03/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 03/2014
2	Toll-Like Receptor 2IBA 01/2017 - 03/2012
2	EndotoxinsIBA 01/2010 - 06/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022
1	AutoantibodiesIBA 12/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022
1	Complement Factor H (Factor H)IBA 12/2022
1	LithiumIBA 10/2022
1	Adenosine Monophosphate (AMP)IBA 07/2022
1	tau Proteins (tau Protein)IBA 04/2022
1	AnticoagulantsIBA 04/2022
1	FructoseIBA 03/2022
1	SaltsIBA 03/2022
1	SodiumIBA 03/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2022
1	gamma-Aminobutyric Acid (GABA)IBA 02/2022
1	Cholinergic ReceptorsIBA 01/2022
1	CausticsIBA 01/2022
1	TrisaccharidesIBA 01/2022
1	HydrolasesIBA 01/2022
1	OligosaccharidesIBA 01/2022
1	VO-OHpicIBA 01/2022
1	OX40 LigandIBA 01/2022
1	Colistin (Coly-Mycin)FDA Link 12/2021
1	Polymyxin B (Aerosporin)FDA LinkGeneric 12/2021
1	Staphylococcal Protein A (Protein A)IBA 12/2021
1	sintilimabIBA 11/2021
1	IceIBA 11/2021
1	Rituximab (Mabthera)FDA Link 10/2021
1	Azathioprine (Imuran)FDA LinkGeneric 10/2021

Therapy/Procedure

9	Therapeutics 04/2022 - 05/2016
3	Drug Therapy (Chemotherapy) 11/2021 - 01/2018
2	Chemoradiotherapy 11/2021 - 11/2018
2	Artificial Respiration (Mechanical Ventilation) 03/2021 - 05/2014
2	Radiotherapy 01/2018 - 07/2017
1	Photothermal Therapy 02/2022
1	Phototherapy (Light Therapy) 01/2022
1	Induced Hyperthermia (Thermotherapy) 01/2022
1	Neoadjuvant Therapy 11/2021